- 209. Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE: Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int 2005;16:468-74.
- 210. Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, Genant HK, Hochberg MC, Ensrud KE, Hillier TA, Cauley JA: Risk factors for a first-incident radiographic vertebral fracture in women > 65 years of age: the Study of Osteoporotic Fractures. J Bone Miner Res 2005;20:131-40.
- 211. Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, Kagan R, Chen E, Petruschke RA, Thompson DE, de Papp AE: Treatment with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized, double-blind study. J Bone Miner Res 2005;20:141-51.
- 212. Cauley JA, Lui L-Y, Stone KL, Hillier TA, Zmuda JM, Hochberg MC, Beck TJ, Ensrud K: Longitudinal study of changes in hip bone mineral density among Caucasian and African-American women. J AmGeriatr Soc. 2005;53:183-9.
- 213. Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM: Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African-Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum. 2005;52:105-11.
- 214. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, Labonte F, Beaudoin G, Bloch DA, Choquette D, Haraoui B, Altman RD, Hochberg M, Meyer JM, Cline GA, Pelletier JP: Meniscal tear and extrusion are strongly associcated with progression of knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis. 2005;64:556-63
- 215. Jordan JM, De Roos AJ, Renner JB, Luta G, Cohen A, Craft N, Helmick CG, Hochberg MC, Arab L: A case-control study of serum tocopherol levels and the alpha- to gamma- tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. AmJ Epidemiol 2004;159:968-77.
- 216. Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE: The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arth Rheum 2005;34:819-36.
- 217. Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Guesens P, Ross PD, Baran D, for the FIT Research Group: Effect of alendronate of the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res: 2005;20:971-6.
- 218. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES, for the Study of Osteoporotic Fractures Research Group: Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005;90:2787-93.
- 219. Cauley JA, Lui LY, Ensrud KE, Zmuda JM, Stone KL, Hochberg MC, Cummings SR: Bone mineral density and the risk on incident non-spine fractures in black and white women: The Study of Osteoporotic Fractures. J.A.M.A. 2005;293:2102-8.
- 220. Moffett SP, Zmuda JM, Oakley JI, Beck TJ, Cauley JA, Stone KL, Lui LY, Ensrud KE, Hillier TA, Hochberg MC, Morin P, Peltz G, Greene D, Cummings SR. Tumor Necrosis Factor Alpha Polymorphism, Bone Strength Phenotypes, and the Risk of Fracture in Older Women. J Clin Endocrinol Metab 2005;90:3491-7.
- 221. Lian K, Zmuda JM, Nevitt MC, Lui L, Hochberg MC, Greene D, Li J, Wang J, Lane NE: Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated